Retinal Photocoagulation Laser

• Fine control of laser output to delivery visible or non-visible laser applications.
• Ability to "Landmark" the treatment area to confirm laser delivery.
• Available as an upgrade to existing PASCAL, Streamline and Streamline 577 laser systems.

Less patient discomfort
Using lower power and shorter pulses result in less trauma and less pain.

Less "spread" after treatment
Treat closer to the macula; with fewer competing chromophores.

More efficient
Gives more consistent laser lesions without the need for constant power adjustments throughout the procedure.

More Precise
Longer wavelength allows better penetration through cataracts or hazy media to help concentrate laser application.

More discerning visualization
Red-free filers allow better visualization and landmark recognition, making this an exceptional teaching tool. Exclusively available in single-wavelength 577 nm systems.

More versatile and reliable
Known and preferred for use in the macula, the 577 now has 2000 mW of deliverable power, capable of doing all a 532 nm can do, with improved clinical efficiency.

577 nm: EFFICIENT, SAFE AND SECURE
The longer wavelength of the 577 better targets the RPE with less scatter than 532 or 561 nm lasers. The combined absorption by both melanin and the oxyhemoglobin makes the 577 more efficient. Energy is concentrated to a smaller volume allowing use of lower powers and shorter pulse durations.

Versatility of Streamline Modules
Video teaching system with integrated video camera and monitor Patterned Laser Trabeculoplasty (PLT) module.

• New compact space-saving portable design, ideal for use in an outpatient clinic or operating room
• PASCAL precision and control technology at NEW more affordable pricing
• Available in both 532 nm and 577 nm wavelengths
• Adapter compatible with tower style diagnostic slit lamps
• Intuitive touchscreen interface with a variety of patterns
• Dual ports offer the convenience of interchanging between an LIO or laser probe
• Optional Endpoint Management technology for less-damaging sub-threshold treatment of a variety of retinal disorders